To Access the Egyptian COVID-19 Whole Genome by NGS and Compare to the International Worldwide Database
Strain
Strain Study: To Access the Egyptian COVID-19 Whole Genome (Dominant Strain) by Next Generation Sequencing (NGS) and Compare to the International Worldwide Database
1 other identifier
observational
100
1 country
1
Brief Summary
This is an exploratory study that will be performed on confirmed positive COVID-19 samples to identify the dominant viral genome strain in Egyptians using next generation sequencing (NGS).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 13, 2020
CompletedFirst Posted
Study publicly available on registry
April 15, 2020
CompletedStudy Start
First participant enrolled
April 20, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2020
CompletedApril 20, 2020
April 1, 2020
5 months
April 13, 2020
April 17, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Dominant viral genome strain
Identify the dominant viral genome strain in Egyptians With COVID-19 infection using next generation sequencing (NGS)
9 months
Eligibility Criteria
100 cases of COVID-19 samples proved to be positive in Ain Shams University Specialized Hospital labs (at the Universities reference lab) will be tested in the strain study.
You may qualify if:
- Patients With confirmed COVID-19
You may not qualify if:
- inadequate sample of the patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center
Cairo, Non-US, 11556, Egypt
Biospecimen
Nasopharyngeal \& oropharyngeal swabs will be taken from patients with COVID-19
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Faculty of Medicine Ain Shams University Research Institute
Study Record Dates
First Submitted
April 13, 2020
First Posted
April 15, 2020
Study Start
April 20, 2020
Primary Completion
October 1, 2020
Study Completion
December 1, 2020
Last Updated
April 20, 2020
Record last verified: 2020-04
Data Sharing
- IPD Sharing
- Will not share